Detalles de la búsqueda
1.
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med;
387(12): 1089-1098, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36027570
2.
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial.
Circulation;
148(22): 1735-1745, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37632455
3.
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
Circulation;
148(24): 1945-1957, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830208
4.
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation;
147(14): 1067-1078, 2023 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36876483
5.
Heart Failure, Investigator-Reported Sleep Apnea and Dapagliflozin: A Patient-Level Pooled Meta-Analysis of DAPA-HF and DELIVER.
J Card Fail;
30(3): 436-448, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104937
6.
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Eur Heart J;
44(31): 2930-2943, 2023 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220093
7.
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Circulation;
146(16): 1210-1224, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029465
8.
Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.
Am Heart J;
263: 133-140, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37220822
9.
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
Eur Heart J;
43(41): 4406-4417, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36029309
10.
Comparison of different site preparation techniques: quality of planting spots, seedling growth and pine weevil damage.
New For (Dordr);
49(6): 705-722, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30416235
11.
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial.
JACC Heart Fail;
12(4): 631-644, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37767674
12.
Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial.
JAMA Cardiol;
9(2): 144-152, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952176
13.
Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.
Eur J Heart Fail;
2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745498
14.
Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant-level pooled analysis of DAPA-HF and DELIVER.
Eur J Heart Fail;
2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38487939
15.
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER.
JACC Heart Fail;
11(1): 76-89, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599553
16.
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical Trial.
JAMA Cardiol;
8(1): 56-65, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326604
17.
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial.
JAMA Cardiol;
8(6): 554-563, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099283
18.
Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status.
JACC Heart Fail;
11(10): 1380-1393, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37294244
19.
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER.
JAMA Cardiol;
8(4): 386-393, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811901
20.
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
JACC Heart Fail;
11(11): 1491-1503, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37226448